375 related articles for article (PubMed ID: 26289651)
1. Reversal of Opioid-Induced Ventilatory Depression Using Low-Dose Naloxone (0.04 mg): a Case Series.
Kim HK; Nelson LS
J Med Toxicol; 2016 Mar; 12(1):107-10. PubMed ID: 26289651
[TBL] [Abstract][Full Text] [Related]
2. Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens: a retrospective cohort study.
Purssell R; Godwin J; Moe J; Buxton J; Crabtree A; Kestler A; DeWitt C; Scheuermeyer F; Erdelyi S; Balshaw R; Rowe A; Cochrane CK; Ng B; Jiang A; Risi A; Ho V; Brubacher JR
Clin Toxicol (Phila); 2021 Jan; 59(1):38-46. PubMed ID: 32401548
[TBL] [Abstract][Full Text] [Related]
3. Use and efficacy of nebulized naloxone in patients with suspected opioid intoxication.
Baumann BM; Patterson RA; Parone DA; Jones MK; Glaspey LJ; Thompson NM; Stauss MP; Haroz R
Am J Emerg Med; 2013 Mar; 31(3):585-8. PubMed ID: 23347721
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Delayed Postoperative Respiratory Depression Assessed from Naloxone Administration.
Weingarten TN; Herasevich V; McGlinch MC; Beatty NC; Christensen ED; Hannifan SK; Koenig AE; Klanke J; Zhu X; Gali B; Schroeder DR; Sprung J
Anesth Analg; 2015 Aug; 121(2):422-9. PubMed ID: 25993390
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the appropriateness of naloxone administration to patients receiving long-term opioid therapy.
Facey C; Brooks D; Boland JW
Hosp Pract (1995); 2016; 44(2):86-91. PubMed ID: 26837434
[TBL] [Abstract][Full Text] [Related]
6. The Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical Specialty.
Connors NJ; Nelson LS
J Med Toxicol; 2016 Sep; 12(3):276-81. PubMed ID: 27271032
[TBL] [Abstract][Full Text] [Related]
7. Acute Opioid Withdrawal Following Intramuscular Administration of Naloxone 1.6 mg: A Prospective Out-Of-Hospital Series.
Isoardi KZ; Parker L; Harris K; Rashford S; Isbister GK
Ann Emerg Med; 2022 Aug; 80(2):120-126. PubMed ID: 35491292
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Two Naloxone Regimens in Opioid-dependent Methadoneoverdosed Patients: A Clinical Trial Study.
Khosravi N; Zamani N; Hassanian-Moghaddam H; Ostadi A; Rahimi M; Kabir A
Curr Clin Pharmacol; 2017; 12(4):259-265. PubMed ID: 29231146
[TBL] [Abstract][Full Text] [Related]
9. Reducing the harm of opioid overdose with the safe use of naloxone : a pharmacologic review.
Kim HK; Nelson LS
Expert Opin Drug Saf; 2015 Jul; 14(7):1137-46. PubMed ID: 25865597
[TBL] [Abstract][Full Text] [Related]
10. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
11. Importance of the correct diagnosis of opioid-induced respiratory depression in adult cancer patients and titration of naloxone.
Boland J; Boland E; Brooks D
Clin Med (Lond); 2013 Apr; 13(2):149-51. PubMed ID: 23681862
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for severe respiratory depression from prescription opioid overdose.
Fox LM; Hoffman RS; Vlahov D; Manini AF
Addiction; 2018 Jan; 113(1):59-66. PubMed ID: 28646524
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial.
Zamani N; Buckley NA; Hassanian-Moghaddam H
Crit Care; 2020 Feb; 24(1):44. PubMed ID: 32033582
[TBL] [Abstract][Full Text] [Related]
14. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.
Carpenter J; Murray BP; Atti S; Moran TP; Yancey A; Morgan B
J Med Toxicol; 2020 Jan; 16(1):41-48. PubMed ID: 31471760
[TBL] [Abstract][Full Text] [Related]
15. Intravenous Buprenorphine: A Substitute for Naloxone in Methadone-Overdosed Patients?
Zamani N; Hassanian-Moghaddam H
Ann Emerg Med; 2017 Jun; 69(6):737-739. PubMed ID: 28237362
[TBL] [Abstract][Full Text] [Related]
16. Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely.
Ryan NM; Isbister GK
Clin Toxicol (Phila); 2015 Jul; 53(6):545-50. PubMed ID: 25901965
[TBL] [Abstract][Full Text] [Related]
17. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
Lewanowitsch T; Miller JH; Irvine RJ
Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783
[TBL] [Abstract][Full Text] [Related]
18. Naloxone--does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose.
Neale J; Strang J
Addiction; 2015 Oct; 110(10):1644-52. PubMed ID: 26119038
[TBL] [Abstract][Full Text] [Related]
19. Take-home naloxone treatment for opioid emergencies: a comparison of routes of administration and associated delivery systems.
Elzey MJ; Fudin J; Edwards ES
Expert Opin Drug Deliv; 2017 Sep; 14(9):1045-1058. PubMed ID: 27606669
[TBL] [Abstract][Full Text] [Related]
20. Comparing methods of naloxone administration: A narrative review.
Fellows SE; Coppola AJ; Gandhi MA
J Opioid Manag; 2017; 13(4):253-260. PubMed ID: 28953317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
